MedPath

Theta Burst Stimulation for Compulsive Behavior Non-invasive Brain Stimulation Study

Not Applicable
Completed
Conditions
Obsessive-Compulsive Disorder
Compulsive Behavior
Interventions
Behavioral: Habit Override Practice
Other: Transcranial Magnetic Stimulation
Registration Number
NCT03265015
Lead Sponsor
University of Pittsburgh
Brief Summary

This project seeks to identify causal neural mechanisms underlying unwanted, repetitive behaviors (compulsions). Using non-invasive brain stimulation coupled with practice in a computer task, we will modulate activity in a target brain region in two directions (up or down) and measure effects on compulsive behaviors and related measures. This work could ultimately lead to the ability to treat compulsions more effectively by targeting the regions of the brain that can help or hinder attempts to overcome compulsions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria

Participants will:

  1. Be between the ages of 18 and 55 years
  2. Endorse problematic compulsive behaviors, per self-report and clinician-administered measures.
  3. Agree to video taping of structured clinical interview
  4. Report that they will reside in the Pittsburgh area for at least 5 weeks
Exclusion Criteria
  1. Failure to meet standard MRI inclusion criteria: those who endorse claustrophobia, those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically implanted metal plates, screws or pins, cochlear implants, implanted uterine devices, metal braces, or other metal objects in their body, especially in the eye. Dental fillings do not present a problem. Plastic or removable dental appliances do not require exclusion. History of significant injury or surgery to the brain or spinal cord that would impair interpretation of results. Pregnancy, determined by pregnancy tests on females.

  2. Medical contraindications for Transcranial Magnetic Stimulation (TMS):

    1. Presence of a neurologic disorder or medication therapy known to alter seizure threshold (e.g., stroke, aneurysm, brain surgery, structural brain lesion, brain injury, frequent/severe headaches)
    2. Recurrent seizures or epilepsy in participant or family history of hereditary epilepsy
    3. Pregnancy
    4. Metallic implants in body or other devices that may be affected by magnetic field
    5. Significant heart disease or cerebrovascular disease
    6. Medications with seizure threshold lowering potential, e.g., clomipramine, Monoamine Oxidase inhibitors (MAOi's), imipramine, clozapine
  3. Acute suicidality or other psychiatric crises requiring treatment escalation

  4. Changes made to treatment regimen within 4 weeks of baseline assessment

  5. Reading level <6th grade

  6. Presence of bipolar, psychotic, autism spectrum, or substance use disorder (i.e. current use of mood altering drugs such as cocaine, cannabis or marijuana, opiates, amphetamines, and barbiturates)

  7. Presence of movement disorder or tics affecting manual responses

  8. Inability to read text from 2 feet away (corrective lenses allowed)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
cTBSTranscranial Magnetic StimulationTranscranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern.
iTBSHabit Override PracticeTranscranial Magnetic Stimulation delivered in an intermittent Theta Burst Stimulation (iTBS) pattern.
iTBSTranscranial Magnetic StimulationTranscranial Magnetic Stimulation delivered in an intermittent Theta Burst Stimulation (iTBS) pattern.
cTBSHabit Override PracticeTranscranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern.
Primary Outcome Measures
NameTimeMethod
functional Magnetic Resonance Imaging (fMRI)10-60min

Brain activation in target region

Secondary Outcome Measures
NameTimeMethod
Habit override task1 week

Percentage of correct responses to each stimulus (0-100%; higher score=better performance)

Duration of compulsive behaviors in response to laboratory triggers90min-1 week

Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: duration of compulsive behavior performance

WHO Disability Assessment Scale 2.01 week

Self-report measure of general functioning and disability

Obsessive Compulsive Inventory-Revised (OCI-R)1 week

Self-report measure of obsessions and compulsions

Effort to resist compulsive behaviors in response to laboratory triggers90min-1 week

Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported effort needed to resist

Intensity of urges to perform compulsive behaviors in response to laboratory triggers90min-1 week

Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported urge intensity

Two-step task90min-1 week

Neuropsychological test of flexible goal-directed cognition

Yale-Brown Obsessive Compulsive Scale (Y-BOCS)1 week

Clinician-administered measurement of obsessions and compulsions

Trial Locations

Locations (1)

Western Psychiatric Institute and Clinic

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath